Coexistence of pustular and vegetative pyoderma gangrenosum in a patient with myelodysplastic syndrome

European Journal of Dermatology

Volumn 22, Issue 5, 2012, Pages 711-712

  Omiya, Wakana ^a   Ujiie, Hideyuki ^a   Akiyama, Masashi ^a,b   Izumi, Kentaro ^a   Shigematsu, Akio ^a   Onozawa, Masahiro ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; PREDNISOLONE;

ACNE; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CAUSE OF DEATH; CELL HYPERPLASIA; CHROMOSOME 1; CHROMOSOME 20Q; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CLINICAL FEATURE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE REDUCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; PANCYTOPENIA; PHYSICAL EXAMINATION; PNEUMONIA; PYODERMA GANGRENOSUM; SKIN DEFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTI-INFLAMMATORY AGENTS; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 20; HUMANS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDNISOLONE; PYODERMA GANGRENOSUM; THROMBOCYTOPENIA;

EID: 84868276596     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2012.1813     Document Type: Article

References (5)

1. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996; 34: 395-409.
2. Chia MW, Teo L, Tay YK, Poh WT. Pustular pyoderma gangrenosum: an uncommon variant which is easily misdiagnosed. Dermatol Online J 2008; 14: 21.
3. Langan SM, Powell FC. Vegetative pyoderma gangrenosum: a report of two new cases and a review of the literature. Int J Dermatol 2005; 44: 623-9.
4. Srivastava M, Rencic A, Nousari HC. A rapidly expanding ulcer. Myelodysplastic syndrome-associated (paraneoplastic) pyoderma gangrenosum. Arch Dermatol 2003; 139: 531-6.
5. Nakano S, Oiso N, Kawada A. Coexisting pustular and ulcerative pyoderma gangrenosum. Eur J Dermatol 2012; 22: 153-4.